Zengjun Li

2.1k citations

132 papers · 1.2k indexed · h-index 19

Impact in

Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Hematology top 5%
- Multiple Myeloma Research and Treatments

Papers in ⓘ

Genetics 46
- Chronic Lymphocytic Leukemia Research 43
Pathology and Forensic Medicine 54
- Lymphoma Diagnosis and Treatment 48

Co-authors: Yanlai Sun (20 shared papers)Jianjun Han (8 shared papers)Zhongfa Xu (9 shared papers)Shuhua Yi (41 shared papers)Dehui Zou (41 shared papers)Lugui Qiu (45 shared papers)Huirong Xu (6 shared papers)Yan Xu (26 shared papers)
Journals: Blood (16 papers)Oncotarget (7 papers)Journal of Clinical Oncology (5 papers)Frontiers in Immunology (3 papers)Therapeutics and Clinical Risk Management (3 papers)
Partner nations: China United States United Kingdom

In The Last Decade

Zengjun Li

115 papers receiving 1.2k citations

Peers

Countries citing papers authored by Zengjun Li

Since Specialization

Citations

This map shows the geographic impact of Zengjun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zengjun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zengjun Li more than expected).

Fields of papers citing papers by Zengjun Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zengjun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zengjun Li. The network helps show where Zengjun Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Zengjun Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zengjun Li Line = papers co-authored together Zengjun Li links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Robotic versus laparoscopic low anterior resection for rectal cancer: a meta-analysis World Journal of Surgical Oncology ·Yanlai Sun, Huirong Xu, Zengjun Li, Jianjun Han, Wentao Song, Junwei Wang, Zhongfa Xu	2016	99
2	Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study Journal of Hematology & Oncology ·Wei Xu, Shenmiao Yang, Keshu Zhou, Ling Pan, Zengjun Li, Jianfeng Zhou, Sujun Gao, Daobin Zhou, Jianda Hu, Ru Feng, Haiwen Huang, Meng Ji, Haiyi Guo, Jane Huang, William Novotny, Shibao Feng, Jianyong Li	2020	92
3	Hedgehog pathway is involved in nitidine chloride induced inhibition of epithelial-mesenchymal transition and cancer stem cells-like properties in breast cancer cells Cell & Bioscience ·Mingjuan Sun, Ning Zhang, Xiaolong Wang, Yaming Li, Wenwen Qi, Hanwen Zhang, Zengjun Li, Qifeng Yang	2016	62
4	A Healthy Dietary Pattern Reduces Lung Cancer Risk: A Systematic Review and Meta-Analysis Nutrients ·Yanlai Sun, Zhenxiang Li, Jianning Li, Zengjun Li, Jianjun Han	2016	56
5	Robotic versus laparoscopic right colectomy: a meta-analysis World Journal of Surgical Oncology ·Huirong Xu, Jianning Li, Yanlai Sun, Zengjun Li, Yanan Zhen, Bin Wang, Zhongfa Xu	2014	54
6	Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients Annals of Hematology ·Gang An, Xiaoqi Qin, Chirag Acharya, Yan Xu, Shuhui Deng, Lihui Shi, Meirong Zang, Weiwei Sui, Shuhua Yi, Zengjun Li, Mu Hao, Xiaoyan Feng, Fengyan Jin, Dehui Zou, Junyuan Qi, Yaozhong Zhao, Yu‐Tzu Tai, Jianxing Wang, Lugui Qiu	2014	50
7	MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma Oncotarget ·Fei Li, Yan Xu, Shuhui Deng, Zengjun Li, Dehui Zou, Shuhua Yi, Weiwei Sui, Mu Hao, Lugui Qiu	2015	46
8	Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis Oncotarget ·Mu Hao, Meirong Zang, Lei Zhao, Shuhui Deng, Yan Xu, Qi Fang, Gang An, Yu Qin, Weiwei Sui, Fei Li, Wenjuan Yang, Zengjun Li, Shuhua Yi, Dehui Zou, Fenghuang Zhan, Lugui Qiu	2016	45
9	Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese BMC Cancer ·Jie Liu, Bao Song, Xueli bai, Wenjian Liu, Zengjun Li, Jia‐Lin Wang, Yan Zheng, Zhehai Wang	2010	39
10	Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC‐803 gastric cancer cells Cell Biochemistry and Function ·Bao Song, Wei‐guo Song, Zengjun Li, Zhongfa Xu, Xingwu Wang, Chuanxi Wang, Jie Liu	2011	38
11	MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia Leukemia & lymphoma ·Keshu Zhou, Shuhua Yi, Zhen Yu, Zengjun Li, Yanying Wang, Dehui Zou, Junyuan Qi, Yaozhong Zhao, Lugui Qiu	2011	30
12	High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival Oncotarget ·Shuhua Yi, Dehui Zou, Chengwen Li, Shizhen Zhong, Weiwei Chen, Zengjun Li, Wenjie Xiong, Wei Liu, Enbin Liu, Rui Cui, Kun Ru, Peihong Zhang, Yan Xu, Gang An, Rui Lv, Junyuan Qi, Jianxiang Wang, Tao Cheng, Lugui Qiu	2015	26
13	Robot-assisted versus conventional laparoscopic operation in anus-preserving rectal cancer: a meta-analysis Therapeutics and Clinical Risk Management ·Cui Yong-zhen, Cheng Li, Zhongfa Xu, Yingming Wang, Yamei Sun, Huirong Xu, Zengjun Li, Yanlai Sun	2017	25
14	Small interfering RNA-mediated downregulation of beta-catenin inhibits invasion and migration of colon cancer cells in vitro Medical Science Monitor ·Jianjun Han, Binbin Gao, Xing Jin, Zhongfa Xu, Zengjun Li, Yanlai Sun, Bao Song	2012	25
15	Expression and mechanism of microRNA-181A on incidence and survival in late liver metastases of colorectal cancer Oncology Reports ·Zengjun Li, Haipeng Wang, Zhongfa Xu, Yanlai Sun, Jianjun Han	2016	23
16	Hsa_circ_0020095 Promotes Oncogenesis and Cisplatin Resistance in Colon Cancer by Sponging miR-487a-3p and Modulating SOX9 Frontiers in Cell and Developmental Biology ·Yanlai Sun, Zhen Cao, Junqi Shan, Yang Gao, Xin Liu, Dejian Ma, Zengjun Li	2021	22
17	Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma Leukemia Research ·Fei Li, Mu Hao, Xiaoyan Feng, Meirong Zang, Yu Qin, Shuhua Yi, Zengjun Li, Yan Xu, Lili Zhou, Weiwei Sui, Shuhui Deng, Dehui Zou, Fenghuang Zhan, Lugui Qiu	2015	22
18	The combination of chidamide with the CHOEP regimen in previously untreated patients with peripheral T-cell lymphoma: a prospective, multicenter, single arm, phase 1b/2 study Cancer Biology and Medicine ·Wei Zhang, Liping Su, Lihong Liu, Yuhuan Gao, Quanshun Wang, Hang Su, Yu-Huan Song, Huilai Zhang, Jing Shen, Hongmei Jing, Shuye Wang, Xinan Cen, Hui Liu, Aichun Liu, Zengjun Li, Jianmin Luo, Jianxia He, Jingwen Wang, Owen A. O’Connor, Daobin Zhou	2021	22
19	BAG3 regulates cell proliferation, migration, and invasion in human colorectal cancer Tumor Biology ·Huiyong Shi, Haidong Xu, Zengjun Li, Yanan Zhen, Bin Wang, Shoujun Huo, Ruixue Xiao, Zhongfa Xu	2015	22
20	Plerixafor and granulocyte‐colony‐stimulating factor for mobilization of hematopoietic stem cells for autologous transplantation in Chinese patients with non−Hodgkin's lymphoma: a randomized Phase 3 study Transfusion ·Jun Zhu, Huiqiang Huang, Huan Chen, Xi Zhang, Zengjun Li, Depei Wu, Daobin Zhou, Yongping Song, Yu Hu, Yingmin Liang, Hanyun Ren, He Huang, Nainong Li, Hu Chen, Jiong Hu, Jianyong Li, Robin Meng, Junlong Wu, Dong Yu, Xiao‐Jun Huang	2017	18

About Zengjun Li

Zengjun Li is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Oncology and Cancer Research, having authored 132 papers that have together received 1.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (48 papers), Chronic Lymphocytic Leukemia Research (43 papers), Multiple Myeloma Research and Treatments (18 papers), Viral-associated cancers and disorders (13 papers), CAR-T cell therapy research (9 papers), Cancer-related gene regulation (9 papers), MicroRNA in disease regulation (9 papers) and Chronic Myeloid Leukemia Treatments (8 papers). The work is most often cited by research in Genetics (251 citations), Hematology (227 citations), Oncology (478 citations), Pathology and Forensic Medicine (301 citations) and Cancer Research (246 citations). Zengjun Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yanlai Sun, Jianjun Han, Zhongfa Xu, Shuhua Yi, Dehui Zou, Lugui Qiu, Huirong Xu, Yan Xu, Jianning Li and Gang An. Their work appears in journals such as Blood, Oncotarget, Journal of Clinical Oncology, Frontiers in Immunology and Therapeutics and Clinical Risk Management.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact